WBIO.L Holdings
WisdomTree BioRevolution UCITS ETF - USD Acc
1W: -0.7%
1M: +3.9%
3M: +11.6%
YTD: +34.9%
1Y: +74.6%
3Y: +42.6%
£2,010.00 ($26.61)
-40.75 (-1.99%)
Weekly Expected Move ±3.4%
£1872
£1941
£2010
£2079
£2148
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$294444
Holdings—
Top 10 Wt—%
Beta0.72
% Profitable—%
Coverage100%
Portfolio Valuation
P/E39.7
P/B8.4
P/S6.8
EV/EBITDA25.6
P/FCF37.1
PEG4.24
Profitability & Returns
Gross Margin64.3%
Net Margin13.1%
ROE16.5%
ROA6.7%
ROIC14.3%
Div Yield0.56%
Leverage & Liquidity
Debt/Equity0.82
Debt/Assets0.32
Net Debt/EBITDA1.5x
Interest Cov9.6x
Current Ratio1.40
Quick Ratio1.08
Growth (YoY)
Revenue+9.6%
Net Income+0.9%
EPS+5.2%
FCF+17.2%
EBITDA+8.2%
Rev CAGR 3Y+31.3%
Quality Scores
Piotroski F4.4
Altman Z12.08
IS Quality55.9
IS Overall46.9
IS Value37.9
Median P/E-2.7
Sector Breakdown
4 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 70 | 90.8% | 2.9 |
| Basic Materials | 7 | 5.4% | -37.9 |
| Consumer Defensive | 3 | 3.5% | 22.8 |
| Other | 7 | 0.3% | — |
Smart Money Overlap
2 holdings with signals
Showing 50 of 87 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 10.21% | $3.0M | 20,088 | -23.8 | $75.4B | Healthcare |
| 2 | Twist Bioscience Corp | TWST | 9.05% | $2.7M | 19,566 | -85.0 | $11.7B | Healthcare |
| 3 | 10X Genomics Inc-Class A | TXG | 3.64% | $1.1M | 15,986 | -158.5 | $11.9B | Healthcare |
| 4 | Eli Lilly & Co | LLY | 3.52% | $1.0M | 1,155 | 38.2 | $1.1T | Healthcare |
| 5 | Natera Inc | NTRA | 3.07% | $903,024 | 2,897 | -301.7 | $58.8B | Healthcare |
| 6 | Tempus Ai Inc | TEM | 2.92% | $857,689 | 13,317 | -53.6 | $13.4B | Healthcare |
| 7 | Johnson & Johnson | JNJ | 2.75% | $809,054 | 3,930 | 29.6 | $617.0B | Healthcare |
| 8 | Immunome Inc | IMNM | 2.01% | $591,381 | 36,034 | -8.2 | $2.0B | Healthcare |
| 9 | United Therapeutics Corp | UTHR | 1.94% | $570,443 | 1,552 | 17.9 | $23.0B | Healthcare |
| 10 | Darling Ingredients Inc | DAR | 1.87% | $548,840 | 11,966 | 16.7 | $10.0B | Consumer Defensive |
| 11 | Thermo Fisher Scientific Inc | TMO | 1.80% | $528,084 | 1,028 | 35.2 | $242.1B | Healthcare |
| 12 | Iovance Biotherapeutics Inc | IOVA | 1.77% | $520,247 | 62,534 | -20.3 | $6.3B | Healthcare |
| 13 | Gilead Sciences Inc | GILD | 1.59% | $468,036 | 4,062 | -55.7 | $179.5B | Healthcare |
| 14 | Revolution Medicines Inc | RVMD | 1.59% | $467,162 | 3,059 | -23.3 | $43.9B | Healthcare |
| 15 | Corteva Inc | CTVA | 1.59% | $466,909 | 7,934 | 7.9 | $8.0B | Basic Materials |
| 16 | Krystal Biotech Inc | KRYS | 1.58% | $465,684 | 1,825 | 39.0 | $9.5B | Healthcare |
| 17 | Roivant Sciences Ltd | ROIV | 1.58% | $463,606 | 16,561 | -94.0 | $25.8B | Healthcare |
| 18 | Amgen Inc | AMGN | 1.56% | $457,694 | 1,446 | 24.8 | $217.5B | Healthcare |
| 19 | Stoke Therapeutics Inc | STOK | 1.55% | $454,983 | 23,570 | -7.6 | $1.7B | Healthcare |
| 20 | Crispr Therapeutics Ag | CRSP | 1.49% | $436,854 | 10,669 | -11.6 | $5.3B | Healthcare |
| 21 | Pfizer Inc | PFE | 1.39% | $409,536 | 18,837 | 36.7 | $158.4B | Healthcare |
| 22 | Bayer AG | BAYN.DE | 1.39% | $408,217 | 9,341 | -25.5 | $44.2B | Healthcare |
| 23 | Beam Therapeutics Inc | BEAM | 1.36% | $400,959 | 21,860 | -29.9 | $2.5B | Healthcare |
| 24 | Bunge Global Sa | BG | 1.34% | $395,290 | 4,788 | 20.7 | $20.5B | Consumer Defensive |
| 25 | Vertex Pharmaceuticals Inc | VRTX | 1.24% | $363,097 | 909 | 29.1 | $128.1B | Healthcare |
| 26 | Novozymes A/S | NZYM-B.CO | 1.23% | $361,100 | 7,361 | 36.4 | $184.5B | Basic Materials |
| 27 | ABSCI Corp | ABSI | 1.22% | $359,469 | 50,038 | -13.8 | $1.9B | Healthcare |
| 28 | Agios Pharmaceuticals Inc | AGIO | 1.22% | $358,967 | 14,189 | -4.5 | $1.9B | Healthcare |
| 29 | Structure Therapeutics Inc | GPCR | 1.21% | $354,179 | 13,343 | -9.1 | $1.6B | Healthcare |
| 30 | Astrazeneca Plc | AZN.L | 1.13% | $331,167 | 2,633 | 23.4 | $184.1B | Healthcare |
| 31 | Novartis AG | NOVN.SW | 1.07% | $315,755 | 2,859 | 21.3 | $221.1B | Healthcare |
| 32 | Biohaven Ltd | BHVN | 1.07% | $315,265 | 31,384 | -2.8 | $1.9B | Healthcare |
| 33 | Protagonist Therapeutics Inc | PTGX | 1.04% | $306,984 | 2,847 | 115.0 | $9.0B | Healthcare |
| 34 | Arcturus Therapeutics Hlgs | ARCT | 1.04% | $304,688 | 27,835 | -3.9 | $370M | Healthcare |
| 35 | Arrowhead Pharmaceuticals Inc | ARWR | 1.04% | $304,455 | 6,144 | -28.7 | $9.0B | Healthcare |
| 36 | Exelixis Inc | EXEL | 0.97% | $286,193 | 6,477 | 17.7 | $14.7B | Healthcare |
| 37 | Veracyte Inc | VCYT | 0.97% | $283,808 | 8,289 | 31.8 | $3.7B | Healthcare |
| 38 | Isis Pharmaceuticals Inc | IONS | 0.93% | $274,282 | 7,951 | -12.6 | $7.2B | Healthcare |
| 39 | Uniqure NV | QURE | 0.91% | $266,841 | 9,013 | -5.8 | $1.6B | Healthcare |
| 40 | Repligen Corp | RGEN | 0.89% | $260,647 | 1,774 | 245.5 | $10.3B | Healthcare |
| 41 | Biontech Se-ADR | BNTX | 0.82% | $240,311 | 3,204 | -12.7 | $24.3B | Healthcare |
| 42 | Argenx Se - Adr | ARGX | 0.82% | $239,934 | 326 | 33.3 | $57.2B | Healthcare |
| 43 | Halozyme Therapeutics Inc | HALO | 0.81% | $236,974 | 2,773 | 31.2 | $13.0B | Healthcare |
| 44 | Danaher Corp | DHR | 0.78% | $228,706 | 1,329 | 37.9 | $150.5B | Healthcare |
| 45 | Cg Oncology Inc | CGON | 0.77% | $226,956 | 4,307 | -25.0 | $5.9B | Healthcare |
| 46 | Biogen Idec Inc | BIIB | 0.76% | $222,111 | 1,283 | 38.7 | $32.5B | Healthcare |
| 47 | Cullinan Therapeutics Inc | CGEM | 0.74% | $218,195 | 19,280 | -4.6 | $953M | Healthcare |
| 48 | Illumina Inc | ILMN | 0.73% | $213,650 | 1,038 | 50.5 | $41.3B | Healthcare |
| 49 | Celldex Therapeutics Inc | CLDX | 0.71% | $209,416 | 8,785 | -7.3 | $2.1B | Healthcare |
| 50 | Viking Therapeutics Inc | VKTX | 0.69% | $202,180 | 8,086 | -6.4 | $3.5B | Healthcare |